Bliss GVS Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Jun' 24	Mar' 24	Dec' 23	Sep' 23	Jun' 23

Sales

148.96

163.82

161.33

171.32

108.99

Operating profit

26.74

25.15

28.66

42.31

11.05

Interest

1.17

1.53

1.79

1.18

1.31

Gross profit

32.41

32.08

34.77

51.74

16.27

EPS (Rs)

1.85

-1.09

1.98

3.25

0.72

Other income

6.84

8.46

7.90

10.61

6.53

Stock adjustment

-19.92

0.87

5.26

-5.27

-7.22

Raw material

91.10

78.50

80.60

83.56

63.17

Power and fuel

-

-

-

-

-

Employee expenses

23.52

20.88

20.97

20.40

20.34

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

27.53

38.41

25.85

30.31

21.65

Provisions made

-

-

-

-

-

Depreciation

6.26

6.23

6.25

5.68

5.36

Taxation

6.73

-3.77

7.80

12.18

3.41

Net profit / loss

19.42

-11.46

20.72

33.89

7.50

Extra ordinary item

-

-41.09

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.49

10.47

10.47

10.44

10.42

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

17.95

15.35

17.76

24.70

10.14

GPM (%)

20.80

18.62

20.54

28.44

14.08

NPM (%)

12.46

-6.65

12.24

18.63

6.49